This inventor holds 3 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Celamerck Gmbh & Co. Kg. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Darmstadt, DE (1976 - 1977)
- Hahnlein, DE (1979)
Company Filing History:

Years Active: 1976-1979
Title: Gunter Lauterbach: Innovator in Pharmaceutical Chemistry
Introduction
Gunter Lauterbach is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents, Lauterbach's work has had a meaningful impact on medical science.
Latest Patents
Lauterbach's latest patents include innovative compounds such as 2-[4-(4-Chlorophenoxymethyl)-phenoxy]-propionic acid. This compound features a formula where R₁ and R₂ can be hydrogen, chlorine, or fluorine. Another significant patent involves phenoxypropionic acid derivatives, which are designed to lower cholesterol and triglyceride blood levels. These derivatives can be synthesized through specific chemical reactions involving phenols and various halogenated compounds.
Career Highlights
Throughout his career, Gunter Lauterbach has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent Gesellschaft mit beschränkter Haftung and Celamerck GmbH & Co. KG. His work in these organizations has allowed him to develop and patent innovative pharmaceutical compounds.
Collaborations
Lauterbach has collaborated with esteemed colleagues such as Erich Schacht and Werner Mehrhof. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Gunter Lauterbach's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile